European phase II trial of an encapsulated cell therapy product [NovaCaps] for advanced, inoperable pancreatic cancer
Phase of Trial: Phase II
Latest Information Update: 14 Aug 2014
At a glance
- Drugs Microencapsulated CYP2B1-expressing cells PharmaCyte Biotech (Primary) ; Ifosfamide
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 14 Aug 2014 Results published in a Nuvilex media release
- 27 Sep 2012 Results will be presented at the International Society for Cell and Gene Therapy (ISCGT) in early October 2012.
- 27 Sep 2012 Status changed from planning to active, no longer recruiting.